Global Neurorehabilitation and Assistive Device Market 2023 by Company, Regions, Type and Application, Forecast to 2029
According to our (Global Info Research) latest study, the global Neurorehabilitation and Assistive Device market size was valued at USD million in 2022 and is forecast to a readjusted size of USD million by 2029 with a CAGR of % during review period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
This report is a detailed and comprehensive analysis for global Neurorehabilitation and Assistive Device market. Both quantitative and qualitative analyses are presented by company, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2023, are provided.
Key Features:
Global Neurorehabilitation and Assistive Device market size and forecasts, in consumption value ($ Million), 2018-2029
Global Neurorehabilitation and Assistive Device market size and forecasts by region and country, in consumption value ($ Million), 2018-2029
Global Neurorehabilitation and Assistive Device market size and forecasts, by Type and by Application, in consumption value ($ Million), 2018-2029
Global Neurorehabilitation and Assistive Device market shares of main players, in revenue ($ Million), 2018-2023
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Neurorehabilitation and Assistive Device
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Neurorehabilitation and Assistive Device market based on the following parameters - company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Medtronic, Abbott Laboratories, Boston Scientific, Bioness and Hocoma, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.
Market segmentation
Neurorehabilitation and Assistive Device market is split by Type and by Application. For the period 2018-2029, the growth among segments provide accurate calculations and forecasts for consumption value by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type
Chapter 1, to describe Neurorehabilitation and Assistive Device product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top players of Neurorehabilitation and Assistive Device, with revenue, gross margin and global market share of Neurorehabilitation and Assistive Device from 2018 to 2023.
Chapter 3, the Neurorehabilitation and Assistive Device competitive situation, revenue and global market share of top players are analyzed emphatically by landscape contrast.
Chapter 4 and 5, to segment the market size by Type and application, with consumption value and growth rate by Type, application, from 2018 to 2029.
Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2018 to 2023.and Neurorehabilitation and Assistive Device market forecast, by regions, type and application, with consumption value, from 2024 to 2029.
Chapter 11, market dynamics, drivers, restraints, trends, Porters Five Forces analysis, and Influence of COVID-19 and Russia-Ukraine War
Chapter 12, the key raw materials and key suppliers, and industry chain of Neurorehabilitation and Assistive Device.
Chapter 13, to describe Neurorehabilitation and Assistive Device research findings and conclusion.
This report is a detailed and comprehensive analysis for global Neurorehabilitation and Assistive Device market. Both quantitative and qualitative analyses are presented by company, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2023, are provided.
Key Features:
Global Neurorehabilitation and Assistive Device market size and forecasts, in consumption value ($ Million), 2018-2029
Global Neurorehabilitation and Assistive Device market size and forecasts by region and country, in consumption value ($ Million), 2018-2029
Global Neurorehabilitation and Assistive Device market size and forecasts, by Type and by Application, in consumption value ($ Million), 2018-2029
Global Neurorehabilitation and Assistive Device market shares of main players, in revenue ($ Million), 2018-2023
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Neurorehabilitation and Assistive Device
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Neurorehabilitation and Assistive Device market based on the following parameters - company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Medtronic, Abbott Laboratories, Boston Scientific, Bioness and Hocoma, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.
Market segmentation
Neurorehabilitation and Assistive Device market is split by Type and by Application. For the period 2018-2029, the growth among segments provide accurate calculations and forecasts for consumption value by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type
- Brain Neurorehabilitation and Assistive Device
- Arms Neurorehabilitation and Assistive Device
- Legs Neurorehabilitation and Assistive Device
- Other
- Hospital
- Rehabilitation Center
- Other
- Medtronic
- Abbott Laboratories
- Boston Scientific
- Bioness
- Hocoma
- Neuronetics
- Magstim
- Ekso Bionics
- Alter G
- MagVenture
- Tyromotion
- Soterix Medical
- Neuroelectrics
- Bionik Laboratories
- Helius Medical
- North America (United States, Canada, and Mexico)
- Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)
- Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia and Rest of Asia-Pacific)
- South America (Brazil, Argentina and Rest of South America)
- Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)
Chapter 1, to describe Neurorehabilitation and Assistive Device product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top players of Neurorehabilitation and Assistive Device, with revenue, gross margin and global market share of Neurorehabilitation and Assistive Device from 2018 to 2023.
Chapter 3, the Neurorehabilitation and Assistive Device competitive situation, revenue and global market share of top players are analyzed emphatically by landscape contrast.
Chapter 4 and 5, to segment the market size by Type and application, with consumption value and growth rate by Type, application, from 2018 to 2029.
Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2018 to 2023.and Neurorehabilitation and Assistive Device market forecast, by regions, type and application, with consumption value, from 2024 to 2029.
Chapter 11, market dynamics, drivers, restraints, trends, Porters Five Forces analysis, and Influence of COVID-19 and Russia-Ukraine War
Chapter 12, the key raw materials and key suppliers, and industry chain of Neurorehabilitation and Assistive Device.
Chapter 13, to describe Neurorehabilitation and Assistive Device research findings and conclusion.
1 MARKET OVERVIEW
1.1 Product Overview and Scope of Neurorehabilitation and Assistive Device
1.2 Market Estimation Caveats and Base Year
1.3 Classification of Neurorehabilitation and Assistive Device by Type
1.3.1 Overview: Global Neurorehabilitation and Assistive Device Market Size by Type: 2018 Versus 2022 Versus 2029
1.3.2 Global Neurorehabilitation and Assistive Device Consumption Value Market Share by Type in 2022
1.3.3 Brain Neurorehabilitation and Assistive Device
1.3.4 Arms Neurorehabilitation and Assistive Device
1.3.5 Legs Neurorehabilitation and Assistive Device
1.3.6 Other
1.4 Global Neurorehabilitation and Assistive Device Market by Application
1.4.1 Overview: Global Neurorehabilitation and Assistive Device Market Size by Application: 2018 Versus 2022 Versus 2029
1.4.2 Hospital
1.4.3 Rehabilitation Center
1.4.4 Other
1.5 Global Neurorehabilitation and Assistive Device Market Size & Forecast
1.6 Global Neurorehabilitation and Assistive Device Market Size and Forecast by Region
1.6.1 Global Neurorehabilitation and Assistive Device Market Size by Region: 2018 VS 2022 VS 2029
1.6.2 Global Neurorehabilitation and Assistive Device Market Size by Region, (2018-2029)
1.6.3 North America Neurorehabilitation and Assistive Device Market Size and Prospect (2018-2029)
1.6.4 Europe Neurorehabilitation and Assistive Device Market Size and Prospect (2018-2029)
1.6.5 Asia-Pacific Neurorehabilitation and Assistive Device Market Size and Prospect (2018-2029)
1.6.6 South America Neurorehabilitation and Assistive Device Market Size and Prospect (2018-2029)
1.6.7 Middle East and Africa Neurorehabilitation and Assistive Device Market Size and Prospect (2018-2029)
2 COMPANY PROFILES
2.1 Medtronic
2.1.1 Medtronic Details
2.1.2 Medtronic Major Business
2.1.3 Medtronic Neurorehabilitation and Assistive Device Product and Solutions
2.1.4 Medtronic Neurorehabilitation and Assistive Device Revenue, Gross Margin and Market Share (2018-2023)
2.1.5 Medtronic Recent Developments and Future Plans
2.2 Abbott Laboratories
2.2.1 Abbott Laboratories Details
2.2.2 Abbott Laboratories Major Business
2.2.3 Abbott Laboratories Neurorehabilitation and Assistive Device Product and Solutions
2.2.4 Abbott Laboratories Neurorehabilitation and Assistive Device Revenue, Gross Margin and Market Share (2018-2023)
2.2.5 Abbott Laboratories Recent Developments and Future Plans
2.3 Boston Scientific
2.3.1 Boston Scientific Details
2.3.2 Boston Scientific Major Business
2.3.3 Boston Scientific Neurorehabilitation and Assistive Device Product and Solutions
2.3.4 Boston Scientific Neurorehabilitation and Assistive Device Revenue, Gross Margin and Market Share (2018-2023)
2.3.5 Boston Scientific Recent Developments and Future Plans
2.4 Bioness
2.4.1 Bioness Details
2.4.2 Bioness Major Business
2.4.3 Bioness Neurorehabilitation and Assistive Device Product and Solutions
2.4.4 Bioness Neurorehabilitation and Assistive Device Revenue, Gross Margin and Market Share (2018-2023)
2.4.5 Bioness Recent Developments and Future Plans
2.5 Hocoma
2.5.1 Hocoma Details
2.5.2 Hocoma Major Business
2.5.3 Hocoma Neurorehabilitation and Assistive Device Product and Solutions
2.5.4 Hocoma Neurorehabilitation and Assistive Device Revenue, Gross Margin and Market Share (2018-2023)
2.5.5 Hocoma Recent Developments and Future Plans
2.6 Neuronetics
2.6.1 Neuronetics Details
2.6.2 Neuronetics Major Business
2.6.3 Neuronetics Neurorehabilitation and Assistive Device Product and Solutions
2.6.4 Neuronetics Neurorehabilitation and Assistive Device Revenue, Gross Margin and Market Share (2018-2023)
2.6.5 Neuronetics Recent Developments and Future Plans
2.7 Magstim
2.7.1 Magstim Details
2.7.2 Magstim Major Business
2.7.3 Magstim Neurorehabilitation and Assistive Device Product and Solutions
2.7.4 Magstim Neurorehabilitation and Assistive Device Revenue, Gross Margin and Market Share (2018-2023)
2.7.5 Magstim Recent Developments and Future Plans
2.8 Ekso Bionics
2.8.1 Ekso Bionics Details
2.8.2 Ekso Bionics Major Business
2.8.3 Ekso Bionics Neurorehabilitation and Assistive Device Product and Solutions
2.8.4 Ekso Bionics Neurorehabilitation and Assistive Device Revenue, Gross Margin and Market Share (2018-2023)
2.8.5 Ekso Bionics Recent Developments and Future Plans
2.9 Alter G
2.9.1 Alter G Details
2.9.2 Alter G Major Business
2.9.3 Alter G Neurorehabilitation and Assistive Device Product and Solutions
2.9.4 Alter G Neurorehabilitation and Assistive Device Revenue, Gross Margin and Market Share (2018-2023)
2.9.5 Alter G Recent Developments and Future Plans
2.10 MagVenture
2.10.1 MagVenture Details
2.10.2 MagVenture Major Business
2.10.3 MagVenture Neurorehabilitation and Assistive Device Product and Solutions
2.10.4 MagVenture Neurorehabilitation and Assistive Device Revenue, Gross Margin and Market Share (2018-2023)
2.10.5 MagVenture Recent Developments and Future Plans
2.11 Tyromotion
2.11.1 Tyromotion Details
2.11.2 Tyromotion Major Business
2.11.3 Tyromotion Neurorehabilitation and Assistive Device Product and Solutions
2.11.4 Tyromotion Neurorehabilitation and Assistive Device Revenue, Gross Margin and Market Share (2018-2023)
2.11.5 Tyromotion Recent Developments and Future Plans
2.12 Soterix Medical
2.12.1 Soterix Medical Details
2.12.2 Soterix Medical Major Business
2.12.3 Soterix Medical Neurorehabilitation and Assistive Device Product and Solutions
2.12.4 Soterix Medical Neurorehabilitation and Assistive Device Revenue, Gross Margin and Market Share (2018-2023)
2.12.5 Soterix Medical Recent Developments and Future Plans
2.13 Neuroelectrics
2.13.1 Neuroelectrics Details
2.13.2 Neuroelectrics Major Business
2.13.3 Neuroelectrics Neurorehabilitation and Assistive Device Product and Solutions
2.13.4 Neuroelectrics Neurorehabilitation and Assistive Device Revenue, Gross Margin and Market Share (2018-2023)
2.13.5 Neuroelectrics Recent Developments and Future Plans
2.14 Bionik Laboratories
2.14.1 Bionik Laboratories Details
2.14.2 Bionik Laboratories Major Business
2.14.3 Bionik Laboratories Neurorehabilitation and Assistive Device Product and Solutions
2.14.4 Bionik Laboratories Neurorehabilitation and Assistive Device Revenue, Gross Margin and Market Share (2018-2023)
2.14.5 Bionik Laboratories Recent Developments and Future Plans
2.15 Helius Medical
2.15.1 Helius Medical Details
2.15.2 Helius Medical Major Business
2.15.3 Helius Medical Neurorehabilitation and Assistive Device Product and Solutions
2.15.4 Helius Medical Neurorehabilitation and Assistive Device Revenue, Gross Margin and Market Share (2018-2023)
2.15.5 Helius Medical Recent Developments and Future Plans
3 MARKET COMPETITION, BY PLAYERS
3.1 Global Neurorehabilitation and Assistive Device Revenue and Share by Players (2018-2023)
3.2 Market Share Analysis (2022)
3.2.1 Market Share of Neurorehabilitation and Assistive Device by Company Revenue
3.2.2 Top 3 Neurorehabilitation and Assistive Device Players Market Share in 2022
3.2.3 Top 6 Neurorehabilitation and Assistive Device Players Market Share in 2022
3.3 Neurorehabilitation and Assistive Device Market: Overall Company Footprint Analysis
3.3.1 Neurorehabilitation and Assistive Device Market: Region Footprint
3.3.2 Neurorehabilitation and Assistive Device Market: Company Product Type Footprint
3.3.3 Neurorehabilitation and Assistive Device Market: Company Product Application Footprint
3.4 New Market Entrants and Barriers to Market Entry
3.5 Mergers, Acquisition, Agreements, and Collaborations
4 MARKET SIZE SEGMENT BY TYPE
4.1 Global Neurorehabilitation and Assistive Device Consumption Value and Market Share by Type (2018-2023)
4.2 Global Neurorehabilitation and Assistive Device Market Forecast by Type (2024-2029)
5 MARKET SIZE SEGMENT BY APPLICATION
5.1 Global Neurorehabilitation and Assistive Device Consumption Value Market Share by Application (2018-2023)
5.2 Global Neurorehabilitation and Assistive Device Market Forecast by Application (2024-2029)
6 NORTH AMERICA
6.1 North America Neurorehabilitation and Assistive Device Consumption Value by Type (2018-2029)
6.2 North America Neurorehabilitation and Assistive Device Consumption Value by Application (2018-2029)
6.3 North America Neurorehabilitation and Assistive Device Market Size by Country
6.3.1 North America Neurorehabilitation and Assistive Device Consumption Value by Country (2018-2029)
6.3.2 United States Neurorehabilitation and Assistive Device Market Size and Forecast (2018-2029)
6.3.3 Canada Neurorehabilitation and Assistive Device Market Size and Forecast (2018-2029)
6.3.4 Mexico Neurorehabilitation and Assistive Device Market Size and Forecast (2018-2029)
7 EUROPE
7.1 Europe Neurorehabilitation and Assistive Device Consumption Value by Type (2018-2029)
7.2 Europe Neurorehabilitation and Assistive Device Consumption Value by Application (2018-2029)
7.3 Europe Neurorehabilitation and Assistive Device Market Size by Country
7.3.1 Europe Neurorehabilitation and Assistive Device Consumption Value by Country (2018-2029)
7.3.2 Germany Neurorehabilitation and Assistive Device Market Size and Forecast (2018-2029)
7.3.3 France Neurorehabilitation and Assistive Device Market Size and Forecast (2018-2029)
7.3.4 United Kingdom Neurorehabilitation and Assistive Device Market Size and Forecast (2018-2029)
7.3.5 Russia Neurorehabilitation and Assistive Device Market Size and Forecast (2018-2029)
7.3.6 Italy Neurorehabilitation and Assistive Device Market Size and Forecast (2018-2029)
8 ASIA-PACIFIC
8.1 Asia-Pacific Neurorehabilitation and Assistive Device Consumption Value by Type (2018-2029)
8.2 Asia-Pacific Neurorehabilitation and Assistive Device Consumption Value by Application (2018-2029)
8.3 Asia-Pacific Neurorehabilitation and Assistive Device Market Size by Region
8.3.1 Asia-Pacific Neurorehabilitation and Assistive Device Consumption Value by Region (2018-2029)
8.3.2 China Neurorehabilitation and Assistive Device Market Size and Forecast (2018-2029)
8.3.3 Japan Neurorehabilitation and Assistive Device Market Size and Forecast (2018-2029)
8.3.4 South Korea Neurorehabilitation and Assistive Device Market Size and Forecast (2018-2029)
8.3.5 India Neurorehabilitation and Assistive Device Market Size and Forecast (2018-2029)
8.3.6 Southeast Asia Neurorehabilitation and Assistive Device Market Size and Forecast (2018-2029)
8.3.7 Australia Neurorehabilitation and Assistive Device Market Size and Forecast (2018-2029)
9 SOUTH AMERICA
9.1 South America Neurorehabilitation and Assistive Device Consumption Value by Type (2018-2029)
9.2 South America Neurorehabilitation and Assistive Device Consumption Value by Application (2018-2029)
9.3 South America Neurorehabilitation and Assistive Device Market Size by Country
9.3.1 South America Neurorehabilitation and Assistive Device Consumption Value by Country (2018-2029)
9.3.2 Brazil Neurorehabilitation and Assistive Device Market Size and Forecast (2018-2029)
9.3.3 Argentina Neurorehabilitation and Assistive Device Market Size and Forecast (2018-2029)
10 MIDDLE EAST & AFRICA
10.1 Middle East & Africa Neurorehabilitation and Assistive Device Consumption Value by Type (2018-2029)
10.2 Middle East & Africa Neurorehabilitation and Assistive Device Consumption Value by Application (2018-2029)
10.3 Middle East & Africa Neurorehabilitation and Assistive Device Market Size by Country
10.3.1 Middle East & Africa Neurorehabilitation and Assistive Device Consumption Value by Country (2018-2029)
10.3.2 Turkey Neurorehabilitation and Assistive Device Market Size and Forecast (2018-2029)
10.3.3 Saudi Arabia Neurorehabilitation and Assistive Device Market Size and Forecast (2018-2029)
10.3.4 UAE Neurorehabilitation and Assistive Device Market Size and Forecast (2018-2029)
11 MARKET DYNAMICS
11.1 Neurorehabilitation and Assistive Device Market Drivers
11.2 Neurorehabilitation and Assistive Device Market Restraints
11.3 Neurorehabilitation and Assistive Device Trends Analysis
11.4 Porters Five Forces Analysis
11.4.1 Threat of New Entrants
11.4.2 Bargaining Power of Suppliers
11.4.3 Bargaining Power of Buyers
11.4.4 Threat of Substitutes
11.4.5 Competitive Rivalry
11.5 Influence of COVID-19 and Russia-Ukraine War
11.5.1 Influence of COVID-19
11.5.2 Influence of Russia-Ukraine War
12 INDUSTRY CHAIN ANALYSIS
12.1 Neurorehabilitation and Assistive Device Industry Chain
12.2 Neurorehabilitation and Assistive Device Upstream Analysis
12.3 Neurorehabilitation and Assistive Device Midstream Analysis
12.4 Neurorehabilitation and Assistive Device Downstream Analysis
13 RESEARCH FINDINGS AND CONCLUSION
14 APPENDIX
14.1 Methodology
14.2 Research Process and Data Source
14.3 Disclaimer
1.1 Product Overview and Scope of Neurorehabilitation and Assistive Device
1.2 Market Estimation Caveats and Base Year
1.3 Classification of Neurorehabilitation and Assistive Device by Type
1.3.1 Overview: Global Neurorehabilitation and Assistive Device Market Size by Type: 2018 Versus 2022 Versus 2029
1.3.2 Global Neurorehabilitation and Assistive Device Consumption Value Market Share by Type in 2022
1.3.3 Brain Neurorehabilitation and Assistive Device
1.3.4 Arms Neurorehabilitation and Assistive Device
1.3.5 Legs Neurorehabilitation and Assistive Device
1.3.6 Other
1.4 Global Neurorehabilitation and Assistive Device Market by Application
1.4.1 Overview: Global Neurorehabilitation and Assistive Device Market Size by Application: 2018 Versus 2022 Versus 2029
1.4.2 Hospital
1.4.3 Rehabilitation Center
1.4.4 Other
1.5 Global Neurorehabilitation and Assistive Device Market Size & Forecast
1.6 Global Neurorehabilitation and Assistive Device Market Size and Forecast by Region
1.6.1 Global Neurorehabilitation and Assistive Device Market Size by Region: 2018 VS 2022 VS 2029
1.6.2 Global Neurorehabilitation and Assistive Device Market Size by Region, (2018-2029)
1.6.3 North America Neurorehabilitation and Assistive Device Market Size and Prospect (2018-2029)
1.6.4 Europe Neurorehabilitation and Assistive Device Market Size and Prospect (2018-2029)
1.6.5 Asia-Pacific Neurorehabilitation and Assistive Device Market Size and Prospect (2018-2029)
1.6.6 South America Neurorehabilitation and Assistive Device Market Size and Prospect (2018-2029)
1.6.7 Middle East and Africa Neurorehabilitation and Assistive Device Market Size and Prospect (2018-2029)
2 COMPANY PROFILES
2.1 Medtronic
2.1.1 Medtronic Details
2.1.2 Medtronic Major Business
2.1.3 Medtronic Neurorehabilitation and Assistive Device Product and Solutions
2.1.4 Medtronic Neurorehabilitation and Assistive Device Revenue, Gross Margin and Market Share (2018-2023)
2.1.5 Medtronic Recent Developments and Future Plans
2.2 Abbott Laboratories
2.2.1 Abbott Laboratories Details
2.2.2 Abbott Laboratories Major Business
2.2.3 Abbott Laboratories Neurorehabilitation and Assistive Device Product and Solutions
2.2.4 Abbott Laboratories Neurorehabilitation and Assistive Device Revenue, Gross Margin and Market Share (2018-2023)
2.2.5 Abbott Laboratories Recent Developments and Future Plans
2.3 Boston Scientific
2.3.1 Boston Scientific Details
2.3.2 Boston Scientific Major Business
2.3.3 Boston Scientific Neurorehabilitation and Assistive Device Product and Solutions
2.3.4 Boston Scientific Neurorehabilitation and Assistive Device Revenue, Gross Margin and Market Share (2018-2023)
2.3.5 Boston Scientific Recent Developments and Future Plans
2.4 Bioness
2.4.1 Bioness Details
2.4.2 Bioness Major Business
2.4.3 Bioness Neurorehabilitation and Assistive Device Product and Solutions
2.4.4 Bioness Neurorehabilitation and Assistive Device Revenue, Gross Margin and Market Share (2018-2023)
2.4.5 Bioness Recent Developments and Future Plans
2.5 Hocoma
2.5.1 Hocoma Details
2.5.2 Hocoma Major Business
2.5.3 Hocoma Neurorehabilitation and Assistive Device Product and Solutions
2.5.4 Hocoma Neurorehabilitation and Assistive Device Revenue, Gross Margin and Market Share (2018-2023)
2.5.5 Hocoma Recent Developments and Future Plans
2.6 Neuronetics
2.6.1 Neuronetics Details
2.6.2 Neuronetics Major Business
2.6.3 Neuronetics Neurorehabilitation and Assistive Device Product and Solutions
2.6.4 Neuronetics Neurorehabilitation and Assistive Device Revenue, Gross Margin and Market Share (2018-2023)
2.6.5 Neuronetics Recent Developments and Future Plans
2.7 Magstim
2.7.1 Magstim Details
2.7.2 Magstim Major Business
2.7.3 Magstim Neurorehabilitation and Assistive Device Product and Solutions
2.7.4 Magstim Neurorehabilitation and Assistive Device Revenue, Gross Margin and Market Share (2018-2023)
2.7.5 Magstim Recent Developments and Future Plans
2.8 Ekso Bionics
2.8.1 Ekso Bionics Details
2.8.2 Ekso Bionics Major Business
2.8.3 Ekso Bionics Neurorehabilitation and Assistive Device Product and Solutions
2.8.4 Ekso Bionics Neurorehabilitation and Assistive Device Revenue, Gross Margin and Market Share (2018-2023)
2.8.5 Ekso Bionics Recent Developments and Future Plans
2.9 Alter G
2.9.1 Alter G Details
2.9.2 Alter G Major Business
2.9.3 Alter G Neurorehabilitation and Assistive Device Product and Solutions
2.9.4 Alter G Neurorehabilitation and Assistive Device Revenue, Gross Margin and Market Share (2018-2023)
2.9.5 Alter G Recent Developments and Future Plans
2.10 MagVenture
2.10.1 MagVenture Details
2.10.2 MagVenture Major Business
2.10.3 MagVenture Neurorehabilitation and Assistive Device Product and Solutions
2.10.4 MagVenture Neurorehabilitation and Assistive Device Revenue, Gross Margin and Market Share (2018-2023)
2.10.5 MagVenture Recent Developments and Future Plans
2.11 Tyromotion
2.11.1 Tyromotion Details
2.11.2 Tyromotion Major Business
2.11.3 Tyromotion Neurorehabilitation and Assistive Device Product and Solutions
2.11.4 Tyromotion Neurorehabilitation and Assistive Device Revenue, Gross Margin and Market Share (2018-2023)
2.11.5 Tyromotion Recent Developments and Future Plans
2.12 Soterix Medical
2.12.1 Soterix Medical Details
2.12.2 Soterix Medical Major Business
2.12.3 Soterix Medical Neurorehabilitation and Assistive Device Product and Solutions
2.12.4 Soterix Medical Neurorehabilitation and Assistive Device Revenue, Gross Margin and Market Share (2018-2023)
2.12.5 Soterix Medical Recent Developments and Future Plans
2.13 Neuroelectrics
2.13.1 Neuroelectrics Details
2.13.2 Neuroelectrics Major Business
2.13.3 Neuroelectrics Neurorehabilitation and Assistive Device Product and Solutions
2.13.4 Neuroelectrics Neurorehabilitation and Assistive Device Revenue, Gross Margin and Market Share (2018-2023)
2.13.5 Neuroelectrics Recent Developments and Future Plans
2.14 Bionik Laboratories
2.14.1 Bionik Laboratories Details
2.14.2 Bionik Laboratories Major Business
2.14.3 Bionik Laboratories Neurorehabilitation and Assistive Device Product and Solutions
2.14.4 Bionik Laboratories Neurorehabilitation and Assistive Device Revenue, Gross Margin and Market Share (2018-2023)
2.14.5 Bionik Laboratories Recent Developments and Future Plans
2.15 Helius Medical
2.15.1 Helius Medical Details
2.15.2 Helius Medical Major Business
2.15.3 Helius Medical Neurorehabilitation and Assistive Device Product and Solutions
2.15.4 Helius Medical Neurorehabilitation and Assistive Device Revenue, Gross Margin and Market Share (2018-2023)
2.15.5 Helius Medical Recent Developments and Future Plans
3 MARKET COMPETITION, BY PLAYERS
3.1 Global Neurorehabilitation and Assistive Device Revenue and Share by Players (2018-2023)
3.2 Market Share Analysis (2022)
3.2.1 Market Share of Neurorehabilitation and Assistive Device by Company Revenue
3.2.2 Top 3 Neurorehabilitation and Assistive Device Players Market Share in 2022
3.2.3 Top 6 Neurorehabilitation and Assistive Device Players Market Share in 2022
3.3 Neurorehabilitation and Assistive Device Market: Overall Company Footprint Analysis
3.3.1 Neurorehabilitation and Assistive Device Market: Region Footprint
3.3.2 Neurorehabilitation and Assistive Device Market: Company Product Type Footprint
3.3.3 Neurorehabilitation and Assistive Device Market: Company Product Application Footprint
3.4 New Market Entrants and Barriers to Market Entry
3.5 Mergers, Acquisition, Agreements, and Collaborations
4 MARKET SIZE SEGMENT BY TYPE
4.1 Global Neurorehabilitation and Assistive Device Consumption Value and Market Share by Type (2018-2023)
4.2 Global Neurorehabilitation and Assistive Device Market Forecast by Type (2024-2029)
5 MARKET SIZE SEGMENT BY APPLICATION
5.1 Global Neurorehabilitation and Assistive Device Consumption Value Market Share by Application (2018-2023)
5.2 Global Neurorehabilitation and Assistive Device Market Forecast by Application (2024-2029)
6 NORTH AMERICA
6.1 North America Neurorehabilitation and Assistive Device Consumption Value by Type (2018-2029)
6.2 North America Neurorehabilitation and Assistive Device Consumption Value by Application (2018-2029)
6.3 North America Neurorehabilitation and Assistive Device Market Size by Country
6.3.1 North America Neurorehabilitation and Assistive Device Consumption Value by Country (2018-2029)
6.3.2 United States Neurorehabilitation and Assistive Device Market Size and Forecast (2018-2029)
6.3.3 Canada Neurorehabilitation and Assistive Device Market Size and Forecast (2018-2029)
6.3.4 Mexico Neurorehabilitation and Assistive Device Market Size and Forecast (2018-2029)
7 EUROPE
7.1 Europe Neurorehabilitation and Assistive Device Consumption Value by Type (2018-2029)
7.2 Europe Neurorehabilitation and Assistive Device Consumption Value by Application (2018-2029)
7.3 Europe Neurorehabilitation and Assistive Device Market Size by Country
7.3.1 Europe Neurorehabilitation and Assistive Device Consumption Value by Country (2018-2029)
7.3.2 Germany Neurorehabilitation and Assistive Device Market Size and Forecast (2018-2029)
7.3.3 France Neurorehabilitation and Assistive Device Market Size and Forecast (2018-2029)
7.3.4 United Kingdom Neurorehabilitation and Assistive Device Market Size and Forecast (2018-2029)
7.3.5 Russia Neurorehabilitation and Assistive Device Market Size and Forecast (2018-2029)
7.3.6 Italy Neurorehabilitation and Assistive Device Market Size and Forecast (2018-2029)
8 ASIA-PACIFIC
8.1 Asia-Pacific Neurorehabilitation and Assistive Device Consumption Value by Type (2018-2029)
8.2 Asia-Pacific Neurorehabilitation and Assistive Device Consumption Value by Application (2018-2029)
8.3 Asia-Pacific Neurorehabilitation and Assistive Device Market Size by Region
8.3.1 Asia-Pacific Neurorehabilitation and Assistive Device Consumption Value by Region (2018-2029)
8.3.2 China Neurorehabilitation and Assistive Device Market Size and Forecast (2018-2029)
8.3.3 Japan Neurorehabilitation and Assistive Device Market Size and Forecast (2018-2029)
8.3.4 South Korea Neurorehabilitation and Assistive Device Market Size and Forecast (2018-2029)
8.3.5 India Neurorehabilitation and Assistive Device Market Size and Forecast (2018-2029)
8.3.6 Southeast Asia Neurorehabilitation and Assistive Device Market Size and Forecast (2018-2029)
8.3.7 Australia Neurorehabilitation and Assistive Device Market Size and Forecast (2018-2029)
9 SOUTH AMERICA
9.1 South America Neurorehabilitation and Assistive Device Consumption Value by Type (2018-2029)
9.2 South America Neurorehabilitation and Assistive Device Consumption Value by Application (2018-2029)
9.3 South America Neurorehabilitation and Assistive Device Market Size by Country
9.3.1 South America Neurorehabilitation and Assistive Device Consumption Value by Country (2018-2029)
9.3.2 Brazil Neurorehabilitation and Assistive Device Market Size and Forecast (2018-2029)
9.3.3 Argentina Neurorehabilitation and Assistive Device Market Size and Forecast (2018-2029)
10 MIDDLE EAST & AFRICA
10.1 Middle East & Africa Neurorehabilitation and Assistive Device Consumption Value by Type (2018-2029)
10.2 Middle East & Africa Neurorehabilitation and Assistive Device Consumption Value by Application (2018-2029)
10.3 Middle East & Africa Neurorehabilitation and Assistive Device Market Size by Country
10.3.1 Middle East & Africa Neurorehabilitation and Assistive Device Consumption Value by Country (2018-2029)
10.3.2 Turkey Neurorehabilitation and Assistive Device Market Size and Forecast (2018-2029)
10.3.3 Saudi Arabia Neurorehabilitation and Assistive Device Market Size and Forecast (2018-2029)
10.3.4 UAE Neurorehabilitation and Assistive Device Market Size and Forecast (2018-2029)
11 MARKET DYNAMICS
11.1 Neurorehabilitation and Assistive Device Market Drivers
11.2 Neurorehabilitation and Assistive Device Market Restraints
11.3 Neurorehabilitation and Assistive Device Trends Analysis
11.4 Porters Five Forces Analysis
11.4.1 Threat of New Entrants
11.4.2 Bargaining Power of Suppliers
11.4.3 Bargaining Power of Buyers
11.4.4 Threat of Substitutes
11.4.5 Competitive Rivalry
11.5 Influence of COVID-19 and Russia-Ukraine War
11.5.1 Influence of COVID-19
11.5.2 Influence of Russia-Ukraine War
12 INDUSTRY CHAIN ANALYSIS
12.1 Neurorehabilitation and Assistive Device Industry Chain
12.2 Neurorehabilitation and Assistive Device Upstream Analysis
12.3 Neurorehabilitation and Assistive Device Midstream Analysis
12.4 Neurorehabilitation and Assistive Device Downstream Analysis
13 RESEARCH FINDINGS AND CONCLUSION
14 APPENDIX
14.1 Methodology
14.2 Research Process and Data Source
14.3 Disclaimer
LIST OF TABLES
Table 1. Global Neurorehabilitation and Assistive Device Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
Table 2. Global Neurorehabilitation and Assistive Device Consumption Value by Application, (USD Million), 2018 & 2022 & 2029
Table 3. Global Neurorehabilitation and Assistive Device Consumption Value by Region (2018-2023) & (USD Million)
Table 4. Global Neurorehabilitation and Assistive Device Consumption Value by Region (2024-2029) & (USD Million)
Table 5. Medtronic Company Information, Head Office, and Major Competitors
Table 6. Medtronic Major Business
Table 7. Medtronic Neurorehabilitation and Assistive Device Product and Solutions
Table 8. Medtronic Neurorehabilitation and Assistive Device Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 9. Medtronic Recent Developments and Future Plans
Table 10. Abbott Laboratories Company Information, Head Office, and Major Competitors
Table 11. Abbott Laboratories Major Business
Table 12. Abbott Laboratories Neurorehabilitation and Assistive Device Product and Solutions
Table 13. Abbott Laboratories Neurorehabilitation and Assistive Device Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 14. Abbott Laboratories Recent Developments and Future Plans
Table 15. Boston Scientific Company Information, Head Office, and Major Competitors
Table 16. Boston Scientific Major Business
Table 17. Boston Scientific Neurorehabilitation and Assistive Device Product and Solutions
Table 18. Boston Scientific Neurorehabilitation and Assistive Device Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 19. Boston Scientific Recent Developments and Future Plans
Table 20. Bioness Company Information, Head Office, and Major Competitors
Table 21. Bioness Major Business
Table 22. Bioness Neurorehabilitation and Assistive Device Product and Solutions
Table 23. Bioness Neurorehabilitation and Assistive Device Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 24. Bioness Recent Developments and Future Plans
Table 25. Hocoma Company Information, Head Office, and Major Competitors
Table 26. Hocoma Major Business
Table 27. Hocoma Neurorehabilitation and Assistive Device Product and Solutions
Table 28. Hocoma Neurorehabilitation and Assistive Device Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 29. Hocoma Recent Developments and Future Plans
Table 30. Neuronetics Company Information, Head Office, and Major Competitors
Table 31. Neuronetics Major Business
Table 32. Neuronetics Neurorehabilitation and Assistive Device Product and Solutions
Table 33. Neuronetics Neurorehabilitation and Assistive Device Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 34. Neuronetics Recent Developments and Future Plans
Table 35. Magstim Company Information, Head Office, and Major Competitors
Table 36. Magstim Major Business
Table 37. Magstim Neurorehabilitation and Assistive Device Product and Solutions
Table 38. Magstim Neurorehabilitation and Assistive Device Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 39. Magstim Recent Developments and Future Plans
Table 40. Ekso Bionics Company Information, Head Office, and Major Competitors
Table 41. Ekso Bionics Major Business
Table 42. Ekso Bionics Neurorehabilitation and Assistive Device Product and Solutions
Table 43. Ekso Bionics Neurorehabilitation and Assistive Device Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 44. Ekso Bionics Recent Developments and Future Plans
Table 45. Alter G Company Information, Head Office, and Major Competitors
Table 46. Alter G Major Business
Table 47. Alter G Neurorehabilitation and Assistive Device Product and Solutions
Table 48. Alter G Neurorehabilitation and Assistive Device Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 49. Alter G Recent Developments and Future Plans
Table 50. MagVenture Company Information, Head Office, and Major Competitors
Table 51. MagVenture Major Business
Table 52. MagVenture Neurorehabilitation and Assistive Device Product and Solutions
Table 53. MagVenture Neurorehabilitation and Assistive Device Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 54. MagVenture Recent Developments and Future Plans
Table 55. Tyromotion Company Information, Head Office, and Major Competitors
Table 56. Tyromotion Major Business
Table 57. Tyromotion Neurorehabilitation and Assistive Device Product and Solutions
Table 58. Tyromotion Neurorehabilitation and Assistive Device Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 59. Tyromotion Recent Developments and Future Plans
Table 60. Soterix Medical Company Information, Head Office, and Major Competitors
Table 61. Soterix Medical Major Business
Table 62. Soterix Medical Neurorehabilitation and Assistive Device Product and Solutions
Table 63. Soterix Medical Neurorehabilitation and Assistive Device Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 64. Soterix Medical Recent Developments and Future Plans
Table 65. Neuroelectrics Company Information, Head Office, and Major Competitors
Table 66. Neuroelectrics Major Business
Table 67. Neuroelectrics Neurorehabilitation and Assistive Device Product and Solutions
Table 68. Neuroelectrics Neurorehabilitation and Assistive Device Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 69. Neuroelectrics Recent Developments and Future Plans
Table 70. Bionik Laboratories Company Information, Head Office, and Major Competitors
Table 71. Bionik Laboratories Major Business
Table 72. Bionik Laboratories Neurorehabilitation and Assistive Device Product and Solutions
Table 73. Bionik Laboratories Neurorehabilitation and Assistive Device Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 74. Bionik Laboratories Recent Developments and Future Plans
Table 75. Helius Medical Company Information, Head Office, and Major Competitors
Table 76. Helius Medical Major Business
Table 77. Helius Medical Neurorehabilitation and Assistive Device Product and Solutions
Table 78. Helius Medical Neurorehabilitation and Assistive Device Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 79. Helius Medical Recent Developments and Future Plans
Table 80. Global Neurorehabilitation and Assistive Device Revenue (USD Million) by Players (2018-2023)
Table 81. Global Neurorehabilitation and Assistive Device Revenue Share by Players (2018-2023)
Table 82. Breakdown of Neurorehabilitation and Assistive Device by Company Type (Tier 1, Tier 2, and Tier 3)
Table 83. Market Position of Players in Neurorehabilitation and Assistive Device, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2022
Table 84. Head Office of Key Neurorehabilitation and Assistive Device Players
Table 85. Neurorehabilitation and Assistive Device Market: Company Product Type Footprint
Table 86. Neurorehabilitation and Assistive Device Market: Company Product Application Footprint
Table 87. Neurorehabilitation and Assistive Device New Market Entrants and Barriers to Market Entry
Table 88. Neurorehabilitation and Assistive Device Mergers, Acquisition, Agreements, and Collaborations
Table 89. Global Neurorehabilitation and Assistive Device Consumption Value (USD Million) by Type (2018-2023)
Table 90. Global Neurorehabilitation and Assistive Device Consumption Value Share by Type (2018-2023)
Table 91. Global Neurorehabilitation and Assistive Device Consumption Value Forecast by Type (2024-2029)
Table 92. Global Neurorehabilitation and Assistive Device Consumption Value by Application (2018-2023)
Table 93. Global Neurorehabilitation and Assistive Device Consumption Value Forecast by Application (2024-2029)
Table 94. North America Neurorehabilitation and Assistive Device Consumption Value by Type (2018-2023) & (USD Million)
Table 95. North America Neurorehabilitation and Assistive Device Consumption Value by Type (2024-2029) & (USD Million)
Table 96. North America Neurorehabilitation and Assistive Device Consumption Value by Application (2018-2023) & (USD Million)
Table 97. North America Neurorehabilitation and Assistive Device Consumption Value by Application (2024-2029) & (USD Million)
Table 98. North America Neurorehabilitation and Assistive Device Consumption Value by Country (2018-2023) & (USD Million)
Table 99. North America Neurorehabilitation and Assistive Device Consumption Value by Country (2024-2029) & (USD Million)
Table 100. Europe Neurorehabilitation and Assistive Device Consumption Value by Type (2018-2023) & (USD Million)
Table 101. Europe Neurorehabilitation and Assistive Device Consumption Value by Type (2024-2029) & (USD Million)
Table 102. Europe Neurorehabilitation and Assistive Device Consumption Value by Application (2018-2023) & (USD Million)
Table 103. Europe Neurorehabilitation and Assistive Device Consumption Value by Application (2024-2029) & (USD Million)
Table 104. Europe Neurorehabilitation and Assistive Device Consumption Value by Country (2018-2023) & (USD Million)
Table 105. Europe Neurorehabilitation and Assistive Device Consumption Value by Country (2024-2029) & (USD Million)
Table 106. Asia-Pacific Neurorehabilitation and Assistive Device Consumption Value by Type (2018-2023) & (USD Million)
Table 107. Asia-Pacific Neurorehabilitation and Assistive Device Consumption Value by Type (2024-2029) & (USD Million)
Table 108. Asia-Pacific Neurorehabilitation and Assistive Device Consumption Value by Application (2018-2023) & (USD Million)
Table 109. Asia-Pacific Neurorehabilitation and Assistive Device Consumption Value by Application (2024-2029) & (USD Million)
Table 110. Asia-Pacific Neurorehabilitation and Assistive Device Consumption Value by Region (2018-2023) & (USD Million)
Table 111. Asia-Pacific Neurorehabilitation and Assistive Device Consumption Value by Region (2024-2029) & (USD Million)
Table 112. South America Neurorehabilitation and Assistive Device Consumption Value by Type (2018-2023) & (USD Million)
Table 113. South America Neurorehabilitation and Assistive Device Consumption Value by Type (2024-2029) & (USD Million)
Table 114. South America Neurorehabilitation and Assistive Device Consumption Value by Application (2018-2023) & (USD Million)
Table 115. South America Neurorehabilitation and Assistive Device Consumption Value by Application (2024-2029) & (USD Million)
Table 116. South America Neurorehabilitation and Assistive Device Consumption Value by Country (2018-2023) & (USD Million)
Table 117. South America Neurorehabilitation and Assistive Device Consumption Value by Country (2024-2029) & (USD Million)
Table 118. Middle East & Africa Neurorehabilitation and Assistive Device Consumption Value by Type (2018-2023) & (USD Million)
Table 119. Middle East & Africa Neurorehabilitation and Assistive Device Consumption Value by Type (2024-2029) & (USD Million)
Table 120. Middle East & Africa Neurorehabilitation and Assistive Device Consumption Value by Application (2018-2023) & (USD Million)
Table 121. Middle East & Africa Neurorehabilitation and Assistive Device Consumption Value by Application (2024-2029) & (USD Million)
Table 122. Middle East & Africa Neurorehabilitation and Assistive Device Consumption Value by Country (2018-2023) & (USD Million)
Table 123. Middle East & Africa Neurorehabilitation and Assistive Device Consumption Value by Country (2024-2029) & (USD Million)
Table 124. Neurorehabilitation and Assistive Device Raw Material
Table 125. Key Suppliers of Neurorehabilitation and Assistive Device Raw Materials
Table 1. Global Neurorehabilitation and Assistive Device Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
Table 2. Global Neurorehabilitation and Assistive Device Consumption Value by Application, (USD Million), 2018 & 2022 & 2029
Table 3. Global Neurorehabilitation and Assistive Device Consumption Value by Region (2018-2023) & (USD Million)
Table 4. Global Neurorehabilitation and Assistive Device Consumption Value by Region (2024-2029) & (USD Million)
Table 5. Medtronic Company Information, Head Office, and Major Competitors
Table 6. Medtronic Major Business
Table 7. Medtronic Neurorehabilitation and Assistive Device Product and Solutions
Table 8. Medtronic Neurorehabilitation and Assistive Device Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 9. Medtronic Recent Developments and Future Plans
Table 10. Abbott Laboratories Company Information, Head Office, and Major Competitors
Table 11. Abbott Laboratories Major Business
Table 12. Abbott Laboratories Neurorehabilitation and Assistive Device Product and Solutions
Table 13. Abbott Laboratories Neurorehabilitation and Assistive Device Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 14. Abbott Laboratories Recent Developments and Future Plans
Table 15. Boston Scientific Company Information, Head Office, and Major Competitors
Table 16. Boston Scientific Major Business
Table 17. Boston Scientific Neurorehabilitation and Assistive Device Product and Solutions
Table 18. Boston Scientific Neurorehabilitation and Assistive Device Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 19. Boston Scientific Recent Developments and Future Plans
Table 20. Bioness Company Information, Head Office, and Major Competitors
Table 21. Bioness Major Business
Table 22. Bioness Neurorehabilitation and Assistive Device Product and Solutions
Table 23. Bioness Neurorehabilitation and Assistive Device Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 24. Bioness Recent Developments and Future Plans
Table 25. Hocoma Company Information, Head Office, and Major Competitors
Table 26. Hocoma Major Business
Table 27. Hocoma Neurorehabilitation and Assistive Device Product and Solutions
Table 28. Hocoma Neurorehabilitation and Assistive Device Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 29. Hocoma Recent Developments and Future Plans
Table 30. Neuronetics Company Information, Head Office, and Major Competitors
Table 31. Neuronetics Major Business
Table 32. Neuronetics Neurorehabilitation and Assistive Device Product and Solutions
Table 33. Neuronetics Neurorehabilitation and Assistive Device Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 34. Neuronetics Recent Developments and Future Plans
Table 35. Magstim Company Information, Head Office, and Major Competitors
Table 36. Magstim Major Business
Table 37. Magstim Neurorehabilitation and Assistive Device Product and Solutions
Table 38. Magstim Neurorehabilitation and Assistive Device Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 39. Magstim Recent Developments and Future Plans
Table 40. Ekso Bionics Company Information, Head Office, and Major Competitors
Table 41. Ekso Bionics Major Business
Table 42. Ekso Bionics Neurorehabilitation and Assistive Device Product and Solutions
Table 43. Ekso Bionics Neurorehabilitation and Assistive Device Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 44. Ekso Bionics Recent Developments and Future Plans
Table 45. Alter G Company Information, Head Office, and Major Competitors
Table 46. Alter G Major Business
Table 47. Alter G Neurorehabilitation and Assistive Device Product and Solutions
Table 48. Alter G Neurorehabilitation and Assistive Device Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 49. Alter G Recent Developments and Future Plans
Table 50. MagVenture Company Information, Head Office, and Major Competitors
Table 51. MagVenture Major Business
Table 52. MagVenture Neurorehabilitation and Assistive Device Product and Solutions
Table 53. MagVenture Neurorehabilitation and Assistive Device Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 54. MagVenture Recent Developments and Future Plans
Table 55. Tyromotion Company Information, Head Office, and Major Competitors
Table 56. Tyromotion Major Business
Table 57. Tyromotion Neurorehabilitation and Assistive Device Product and Solutions
Table 58. Tyromotion Neurorehabilitation and Assistive Device Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 59. Tyromotion Recent Developments and Future Plans
Table 60. Soterix Medical Company Information, Head Office, and Major Competitors
Table 61. Soterix Medical Major Business
Table 62. Soterix Medical Neurorehabilitation and Assistive Device Product and Solutions
Table 63. Soterix Medical Neurorehabilitation and Assistive Device Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 64. Soterix Medical Recent Developments and Future Plans
Table 65. Neuroelectrics Company Information, Head Office, and Major Competitors
Table 66. Neuroelectrics Major Business
Table 67. Neuroelectrics Neurorehabilitation and Assistive Device Product and Solutions
Table 68. Neuroelectrics Neurorehabilitation and Assistive Device Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 69. Neuroelectrics Recent Developments and Future Plans
Table 70. Bionik Laboratories Company Information, Head Office, and Major Competitors
Table 71. Bionik Laboratories Major Business
Table 72. Bionik Laboratories Neurorehabilitation and Assistive Device Product and Solutions
Table 73. Bionik Laboratories Neurorehabilitation and Assistive Device Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 74. Bionik Laboratories Recent Developments and Future Plans
Table 75. Helius Medical Company Information, Head Office, and Major Competitors
Table 76. Helius Medical Major Business
Table 77. Helius Medical Neurorehabilitation and Assistive Device Product and Solutions
Table 78. Helius Medical Neurorehabilitation and Assistive Device Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 79. Helius Medical Recent Developments and Future Plans
Table 80. Global Neurorehabilitation and Assistive Device Revenue (USD Million) by Players (2018-2023)
Table 81. Global Neurorehabilitation and Assistive Device Revenue Share by Players (2018-2023)
Table 82. Breakdown of Neurorehabilitation and Assistive Device by Company Type (Tier 1, Tier 2, and Tier 3)
Table 83. Market Position of Players in Neurorehabilitation and Assistive Device, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2022
Table 84. Head Office of Key Neurorehabilitation and Assistive Device Players
Table 85. Neurorehabilitation and Assistive Device Market: Company Product Type Footprint
Table 86. Neurorehabilitation and Assistive Device Market: Company Product Application Footprint
Table 87. Neurorehabilitation and Assistive Device New Market Entrants and Barriers to Market Entry
Table 88. Neurorehabilitation and Assistive Device Mergers, Acquisition, Agreements, and Collaborations
Table 89. Global Neurorehabilitation and Assistive Device Consumption Value (USD Million) by Type (2018-2023)
Table 90. Global Neurorehabilitation and Assistive Device Consumption Value Share by Type (2018-2023)
Table 91. Global Neurorehabilitation and Assistive Device Consumption Value Forecast by Type (2024-2029)
Table 92. Global Neurorehabilitation and Assistive Device Consumption Value by Application (2018-2023)
Table 93. Global Neurorehabilitation and Assistive Device Consumption Value Forecast by Application (2024-2029)
Table 94. North America Neurorehabilitation and Assistive Device Consumption Value by Type (2018-2023) & (USD Million)
Table 95. North America Neurorehabilitation and Assistive Device Consumption Value by Type (2024-2029) & (USD Million)
Table 96. North America Neurorehabilitation and Assistive Device Consumption Value by Application (2018-2023) & (USD Million)
Table 97. North America Neurorehabilitation and Assistive Device Consumption Value by Application (2024-2029) & (USD Million)
Table 98. North America Neurorehabilitation and Assistive Device Consumption Value by Country (2018-2023) & (USD Million)
Table 99. North America Neurorehabilitation and Assistive Device Consumption Value by Country (2024-2029) & (USD Million)
Table 100. Europe Neurorehabilitation and Assistive Device Consumption Value by Type (2018-2023) & (USD Million)
Table 101. Europe Neurorehabilitation and Assistive Device Consumption Value by Type (2024-2029) & (USD Million)
Table 102. Europe Neurorehabilitation and Assistive Device Consumption Value by Application (2018-2023) & (USD Million)
Table 103. Europe Neurorehabilitation and Assistive Device Consumption Value by Application (2024-2029) & (USD Million)
Table 104. Europe Neurorehabilitation and Assistive Device Consumption Value by Country (2018-2023) & (USD Million)
Table 105. Europe Neurorehabilitation and Assistive Device Consumption Value by Country (2024-2029) & (USD Million)
Table 106. Asia-Pacific Neurorehabilitation and Assistive Device Consumption Value by Type (2018-2023) & (USD Million)
Table 107. Asia-Pacific Neurorehabilitation and Assistive Device Consumption Value by Type (2024-2029) & (USD Million)
Table 108. Asia-Pacific Neurorehabilitation and Assistive Device Consumption Value by Application (2018-2023) & (USD Million)
Table 109. Asia-Pacific Neurorehabilitation and Assistive Device Consumption Value by Application (2024-2029) & (USD Million)
Table 110. Asia-Pacific Neurorehabilitation and Assistive Device Consumption Value by Region (2018-2023) & (USD Million)
Table 111. Asia-Pacific Neurorehabilitation and Assistive Device Consumption Value by Region (2024-2029) & (USD Million)
Table 112. South America Neurorehabilitation and Assistive Device Consumption Value by Type (2018-2023) & (USD Million)
Table 113. South America Neurorehabilitation and Assistive Device Consumption Value by Type (2024-2029) & (USD Million)
Table 114. South America Neurorehabilitation and Assistive Device Consumption Value by Application (2018-2023) & (USD Million)
Table 115. South America Neurorehabilitation and Assistive Device Consumption Value by Application (2024-2029) & (USD Million)
Table 116. South America Neurorehabilitation and Assistive Device Consumption Value by Country (2018-2023) & (USD Million)
Table 117. South America Neurorehabilitation and Assistive Device Consumption Value by Country (2024-2029) & (USD Million)
Table 118. Middle East & Africa Neurorehabilitation and Assistive Device Consumption Value by Type (2018-2023) & (USD Million)
Table 119. Middle East & Africa Neurorehabilitation and Assistive Device Consumption Value by Type (2024-2029) & (USD Million)
Table 120. Middle East & Africa Neurorehabilitation and Assistive Device Consumption Value by Application (2018-2023) & (USD Million)
Table 121. Middle East & Africa Neurorehabilitation and Assistive Device Consumption Value by Application (2024-2029) & (USD Million)
Table 122. Middle East & Africa Neurorehabilitation and Assistive Device Consumption Value by Country (2018-2023) & (USD Million)
Table 123. Middle East & Africa Neurorehabilitation and Assistive Device Consumption Value by Country (2024-2029) & (USD Million)
Table 124. Neurorehabilitation and Assistive Device Raw Material
Table 125. Key Suppliers of Neurorehabilitation and Assistive Device Raw Materials
LIST OF FIGURES
Figure 1. Neurorehabilitation and Assistive Device Picture
Figure 2. Global Neurorehabilitation and Assistive Device Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
Figure 3. Global Neurorehabilitation and Assistive Device Consumption Value Market Share by Type in 2022
Figure 4. Brain Neurorehabilitation and Assistive Device
Figure 5. Arms Neurorehabilitation and Assistive Device
Figure 6. Legs Neurorehabilitation and Assistive Device
Figure 7. Other
Figure 8. Global Neurorehabilitation and Assistive Device Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
Figure 9. Neurorehabilitation and Assistive Device Consumption Value Market Share by Application in 2022
Figure 10. Hospital Picture
Figure 11. Rehabilitation Center Picture
Figure 12. Other Picture
Figure 13. Global Neurorehabilitation and Assistive Device Consumption Value, (USD Million): 2018 & 2022 & 2029
Figure 14. Global Neurorehabilitation and Assistive Device Consumption Value and Forecast (2018-2029) & (USD Million)
Figure 15. Global Market Neurorehabilitation and Assistive Device Consumption Value (USD Million) Comparison by Region (2018 & 2022 & 2029)
Figure 16. Global Neurorehabilitation and Assistive Device Consumption Value Market Share by Region (2018-2029)
Figure 17. Global Neurorehabilitation and Assistive Device Consumption Value Market Share by Region in 2022
Figure 18. North America Neurorehabilitation and Assistive Device Consumption Value (2018-2029) & (USD Million)
Figure 19. Europe Neurorehabilitation and Assistive Device Consumption Value (2018-2029) & (USD Million)
Figure 20. Asia-Pacific Neurorehabilitation and Assistive Device Consumption Value (2018-2029) & (USD Million)
Figure 21. South America Neurorehabilitation and Assistive Device Consumption Value (2018-2029) & (USD Million)
Figure 22. Middle East and Africa Neurorehabilitation and Assistive Device Consumption Value (2018-2029) & (USD Million)
Figure 23. Global Neurorehabilitation and Assistive Device Revenue Share by Players in 2022
Figure 24. Neurorehabilitation and Assistive Device Market Share by Company Type (Tier 1, Tier 2 and Tier 3) in 2022
Figure 25. Global Top 3 Players Neurorehabilitation and Assistive Device Market Share in 2022
Figure 26. Global Top 6 Players Neurorehabilitation and Assistive Device Market Share in 2022
Figure 27. Global Neurorehabilitation and Assistive Device Consumption Value Share by Type (2018-2023)
Figure 28. Global Neurorehabilitation and Assistive Device Market Share Forecast by Type (2024-2029)
Figure 29. Global Neurorehabilitation and Assistive Device Consumption Value Share by Application (2018-2023)
Figure 30. Global Neurorehabilitation and Assistive Device Market Share Forecast by Application (2024-2029)
Figure 31. North America Neurorehabilitation and Assistive Device Consumption Value Market Share by Type (2018-2029)
Figure 32. North America Neurorehabilitation and Assistive Device Consumption Value Market Share by Application (2018-2029)
Figure 33. North America Neurorehabilitation and Assistive Device Consumption Value Market Share by Country (2018-2029)
Figure 34. United States Neurorehabilitation and Assistive Device Consumption Value (2018-2029) & (USD Million)
Figure 35. Canada Neurorehabilitation and Assistive Device Consumption Value (2018-2029) & (USD Million)
Figure 36. Mexico Neurorehabilitation and Assistive Device Consumption Value (2018-2029) & (USD Million)
Figure 37. Europe Neurorehabilitation and Assistive Device Consumption Value Market Share by Type (2018-2029)
Figure 38. Europe Neurorehabilitation and Assistive Device Consumption Value Market Share by Application (2018-2029)
Figure 39. Europe Neurorehabilitation and Assistive Device Consumption Value Market Share by Country (2018-2029)
Figure 40. Germany Neurorehabilitation and Assistive Device Consumption Value (2018-2029) & (USD Million)
Figure 41. France Neurorehabilitation and Assistive Device Consumption Value (2018-2029) & (USD Million)
Figure 42. United Kingdom Neurorehabilitation and Assistive Device Consumption Value (2018-2029) & (USD Million)
Figure 43. Russia Neurorehabilitation and Assistive Device Consumption Value (2018-2029) & (USD Million)
Figure 44. Italy Neurorehabilitation and Assistive Device Consumption Value (2018-2029) & (USD Million)
Figure 45. Asia-Pacific Neurorehabilitation and Assistive Device Consumption Value Market Share by Type (2018-2029)
Figure 46. Asia-Pacific Neurorehabilitation and Assistive Device Consumption Value Market Share by Application (2018-2029)
Figure 47. Asia-Pacific Neurorehabilitation and Assistive Device Consumption Value Market Share by Region (2018-2029)
Figure 48. China Neurorehabilitation and Assistive Device Consumption Value (2018-2029) & (USD Million)
Figure 49. Japan Neurorehabilitation and Assistive Device Consumption Value (2018-2029) & (USD Million)
Figure 50. South Korea Neurorehabilitation and Assistive Device Consumption Value (2018-2029) & (USD Million)
Figure 51. India Neurorehabilitation and Assistive Device Consumption Value (2018-2029) & (USD Million)
Figure 52. Southeast Asia Neurorehabilitation and Assistive Device Consumption Value (2018-2029) & (USD Million)
Figure 53. Australia Neurorehabilitation and Assistive Device Consumption Value (2018-2029) & (USD Million)
Figure 54. South America Neurorehabilitation and Assistive Device Consumption Value Market Share by Type (2018-2029)
Figure 55. South America Neurorehabilitation and Assistive Device Consumption Value Market Share by Application (2018-2029)
Figure 56. South America Neurorehabilitation and Assistive Device Consumption Value Market Share by Country (2018-2029)
Figure 57. Brazil Neurorehabilitation and Assistive Device Consumption Value (2018-2029) & (USD Million)
Figure 58. Argentina Neurorehabilitation and Assistive Device Consumption Value (2018-2029) & (USD Million)
Figure 59. Middle East and Africa Neurorehabilitation and Assistive Device Consumption Value Market Share by Type (2018-2029)
Figure 60. Middle East and Africa Neurorehabilitation and Assistive Device Consumption Value Market Share by Application (2018-2029)
Figure 61. Middle East and Africa Neurorehabilitation and Assistive Device Consumption Value Market Share by Country (2018-2029)
Figure 62. Turkey Neurorehabilitation and Assistive Device Consumption Value (2018-2029) & (USD Million)
Figure 63. Saudi Arabia Neurorehabilitation and Assistive Device Consumption Value (2018-2029) & (USD Million)
Figure 64. UAE Neurorehabilitation and Assistive Device Consumption Value (2018-2029) & (USD Million)
Figure 65. Neurorehabilitation and Assistive Device Market Drivers
Figure 66. Neurorehabilitation and Assistive Device Market Restraints
Figure 67. Neurorehabilitation and Assistive Device Market Trends
Figure 68. Porters Five Forces Analysis
Figure 69. Manufacturing Cost Structure Analysis of Neurorehabilitation and Assistive Device in 2022
Figure 70. Manufacturing Process Analysis of Neurorehabilitation and Assistive Device
Figure 71. Neurorehabilitation and Assistive Device Industrial Chain
Figure 72. Methodology
Figure 73. Research Process and Data Source
Figure 1. Neurorehabilitation and Assistive Device Picture
Figure 2. Global Neurorehabilitation and Assistive Device Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
Figure 3. Global Neurorehabilitation and Assistive Device Consumption Value Market Share by Type in 2022
Figure 4. Brain Neurorehabilitation and Assistive Device
Figure 5. Arms Neurorehabilitation and Assistive Device
Figure 6. Legs Neurorehabilitation and Assistive Device
Figure 7. Other
Figure 8. Global Neurorehabilitation and Assistive Device Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
Figure 9. Neurorehabilitation and Assistive Device Consumption Value Market Share by Application in 2022
Figure 10. Hospital Picture
Figure 11. Rehabilitation Center Picture
Figure 12. Other Picture
Figure 13. Global Neurorehabilitation and Assistive Device Consumption Value, (USD Million): 2018 & 2022 & 2029
Figure 14. Global Neurorehabilitation and Assistive Device Consumption Value and Forecast (2018-2029) & (USD Million)
Figure 15. Global Market Neurorehabilitation and Assistive Device Consumption Value (USD Million) Comparison by Region (2018 & 2022 & 2029)
Figure 16. Global Neurorehabilitation and Assistive Device Consumption Value Market Share by Region (2018-2029)
Figure 17. Global Neurorehabilitation and Assistive Device Consumption Value Market Share by Region in 2022
Figure 18. North America Neurorehabilitation and Assistive Device Consumption Value (2018-2029) & (USD Million)
Figure 19. Europe Neurorehabilitation and Assistive Device Consumption Value (2018-2029) & (USD Million)
Figure 20. Asia-Pacific Neurorehabilitation and Assistive Device Consumption Value (2018-2029) & (USD Million)
Figure 21. South America Neurorehabilitation and Assistive Device Consumption Value (2018-2029) & (USD Million)
Figure 22. Middle East and Africa Neurorehabilitation and Assistive Device Consumption Value (2018-2029) & (USD Million)
Figure 23. Global Neurorehabilitation and Assistive Device Revenue Share by Players in 2022
Figure 24. Neurorehabilitation and Assistive Device Market Share by Company Type (Tier 1, Tier 2 and Tier 3) in 2022
Figure 25. Global Top 3 Players Neurorehabilitation and Assistive Device Market Share in 2022
Figure 26. Global Top 6 Players Neurorehabilitation and Assistive Device Market Share in 2022
Figure 27. Global Neurorehabilitation and Assistive Device Consumption Value Share by Type (2018-2023)
Figure 28. Global Neurorehabilitation and Assistive Device Market Share Forecast by Type (2024-2029)
Figure 29. Global Neurorehabilitation and Assistive Device Consumption Value Share by Application (2018-2023)
Figure 30. Global Neurorehabilitation and Assistive Device Market Share Forecast by Application (2024-2029)
Figure 31. North America Neurorehabilitation and Assistive Device Consumption Value Market Share by Type (2018-2029)
Figure 32. North America Neurorehabilitation and Assistive Device Consumption Value Market Share by Application (2018-2029)
Figure 33. North America Neurorehabilitation and Assistive Device Consumption Value Market Share by Country (2018-2029)
Figure 34. United States Neurorehabilitation and Assistive Device Consumption Value (2018-2029) & (USD Million)
Figure 35. Canada Neurorehabilitation and Assistive Device Consumption Value (2018-2029) & (USD Million)
Figure 36. Mexico Neurorehabilitation and Assistive Device Consumption Value (2018-2029) & (USD Million)
Figure 37. Europe Neurorehabilitation and Assistive Device Consumption Value Market Share by Type (2018-2029)
Figure 38. Europe Neurorehabilitation and Assistive Device Consumption Value Market Share by Application (2018-2029)
Figure 39. Europe Neurorehabilitation and Assistive Device Consumption Value Market Share by Country (2018-2029)
Figure 40. Germany Neurorehabilitation and Assistive Device Consumption Value (2018-2029) & (USD Million)
Figure 41. France Neurorehabilitation and Assistive Device Consumption Value (2018-2029) & (USD Million)
Figure 42. United Kingdom Neurorehabilitation and Assistive Device Consumption Value (2018-2029) & (USD Million)
Figure 43. Russia Neurorehabilitation and Assistive Device Consumption Value (2018-2029) & (USD Million)
Figure 44. Italy Neurorehabilitation and Assistive Device Consumption Value (2018-2029) & (USD Million)
Figure 45. Asia-Pacific Neurorehabilitation and Assistive Device Consumption Value Market Share by Type (2018-2029)
Figure 46. Asia-Pacific Neurorehabilitation and Assistive Device Consumption Value Market Share by Application (2018-2029)
Figure 47. Asia-Pacific Neurorehabilitation and Assistive Device Consumption Value Market Share by Region (2018-2029)
Figure 48. China Neurorehabilitation and Assistive Device Consumption Value (2018-2029) & (USD Million)
Figure 49. Japan Neurorehabilitation and Assistive Device Consumption Value (2018-2029) & (USD Million)
Figure 50. South Korea Neurorehabilitation and Assistive Device Consumption Value (2018-2029) & (USD Million)
Figure 51. India Neurorehabilitation and Assistive Device Consumption Value (2018-2029) & (USD Million)
Figure 52. Southeast Asia Neurorehabilitation and Assistive Device Consumption Value (2018-2029) & (USD Million)
Figure 53. Australia Neurorehabilitation and Assistive Device Consumption Value (2018-2029) & (USD Million)
Figure 54. South America Neurorehabilitation and Assistive Device Consumption Value Market Share by Type (2018-2029)
Figure 55. South America Neurorehabilitation and Assistive Device Consumption Value Market Share by Application (2018-2029)
Figure 56. South America Neurorehabilitation and Assistive Device Consumption Value Market Share by Country (2018-2029)
Figure 57. Brazil Neurorehabilitation and Assistive Device Consumption Value (2018-2029) & (USD Million)
Figure 58. Argentina Neurorehabilitation and Assistive Device Consumption Value (2018-2029) & (USD Million)
Figure 59. Middle East and Africa Neurorehabilitation and Assistive Device Consumption Value Market Share by Type (2018-2029)
Figure 60. Middle East and Africa Neurorehabilitation and Assistive Device Consumption Value Market Share by Application (2018-2029)
Figure 61. Middle East and Africa Neurorehabilitation and Assistive Device Consumption Value Market Share by Country (2018-2029)
Figure 62. Turkey Neurorehabilitation and Assistive Device Consumption Value (2018-2029) & (USD Million)
Figure 63. Saudi Arabia Neurorehabilitation and Assistive Device Consumption Value (2018-2029) & (USD Million)
Figure 64. UAE Neurorehabilitation and Assistive Device Consumption Value (2018-2029) & (USD Million)
Figure 65. Neurorehabilitation and Assistive Device Market Drivers
Figure 66. Neurorehabilitation and Assistive Device Market Restraints
Figure 67. Neurorehabilitation and Assistive Device Market Trends
Figure 68. Porters Five Forces Analysis
Figure 69. Manufacturing Cost Structure Analysis of Neurorehabilitation and Assistive Device in 2022
Figure 70. Manufacturing Process Analysis of Neurorehabilitation and Assistive Device
Figure 71. Neurorehabilitation and Assistive Device Industrial Chain
Figure 72. Methodology
Figure 73. Research Process and Data Source
